Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical Imaging

PUBLISHER: Grand View Research | PRODUCT CODE: 1446449

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1446449

Vascular Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Ultrasound, Nuclear Medicine), By End-Use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 105 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Vascular Imaging Market Growth & Trends:

The global vascular imaging market size is expected to reach USD 8.52 billion by 2030, registering a CAGR of 4.19% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiovascular disorders and growing technological advancements in vascular scanning devices are majorly driving the vascular imaging market. In addition, growing funding for developments in vascular imaging devices is further anticipated to fuel the market.

Recent developments in ultrasound technology including 3D visualization and handheld devices are expected to contribute to the vascular imaging market growth. Replacement of 2D technology into 3D has enabled 3D capturing of images without the movement of transducer in real-time. In addition, developments in vector-Doppler technique based on plane-wave imaging is gaining popularity. This method effectively decreases the frame rate (reduces scan-lines) required for focusing an image and more rapidly.

Increasing number of diagnostic imaging centers due to increasing patient pool is an opportunity for the manufacturers to introduce more efficient imaging technologies. Increasing developments in imaging technologies, such as X-ray based analyses and ultrasonography techniques are expected to expand the applications of vascular imaging. These modalities are highly preferred in both palliative and curative care for superior levels of healthcare.

Vascular Imaging Market Report Highlights:

  • By type, non-invasive segment held the largest share in vascular imaging market in 2023 owing to various advantages offered by different techniques, such as patient safety and shorter turnaround time
  • Advantages offered by CT scanners, such as enhanced spatial and temporal resolution, quick technique, and offering of multiple images from different angles with the help of x-ray tube are expected to expand the applications of this modality
  • North America dominated the vascular imaging market in 2023, owing to high prevalence of cardiovascular disorders among geriatric population and well-established healthcare facilities
  • Vascular imaging market in Asia Pacific is expected to witness lucrative growth rate over the forecast period owing to high prevalence of CVDs in lower and middle income economies
Show more
Product Code: GVR-4-68038-020-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Vascular Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of cancer and cardiac diseases
      • 3.2.1.2. Favorable government initiatives
      • 3.2.1.3. Trends of preventive healthcare and disease screening programs
      • 3.2.1.4. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of product
      • 3.2.2.2. Increasing use of refurbished products
  • 3.3. Vascular Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Vascular Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Modality Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Vascular Imaging Market by Modality Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. CT
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. MRI
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Ultrasound
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Nuclear Medicine
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Vascular Imaging Market: End-Use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Vascular Imaging Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Imaging Centers
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Vascular Imaging Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Siemens Healthineers
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott Laboratories
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. GE Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Koninklijke Philips N.V.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Hitachi Medical Corporation.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Samsung Medison Co., Ltd.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Shimadzu Corporation
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Hologic Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Carestream Health Inc...
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
Show more
Product Code: GVR-4-68038-020-0

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 6 U.S. vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 8 Canada vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 11 Europe vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Germany vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 13 Germany vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 15 UK vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 17 France vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 19 Italy vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 21 Spain vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Denmark vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 23 Denmark vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Sweden vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Sweden vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 27 Norway vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 31 China vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 32 China vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 34 Japan vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 36 India vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 37 South Korea vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 38 South Korea vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Australia vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 40 Australia vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Thailand vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 42 Thailand vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Latin America vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Brazil vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 47 Brazil vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 49 Mexico vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 51 Argentina vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 52 MEA vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 54 MEA vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 55 South Africa vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 56 South Africa vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 60 UAE vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 62 Kuwait vascular imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Vascular imaging market: market outlook
  • Fig. 14 Vascular imaging competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Vascular imaging market driver impact
  • Fig. 20 Vascular imaging market restraint impact
  • Fig. 21 Vascular imaging market strategic initiatives analysis
  • Fig. 22 Vascular imaging market: Modality movement analysis
  • Fig. 23 vascular imaging market: Modality outlook and key takeaways
  • Fig. 24 CT market estimates and forecast, 2018 - 2030
  • Fig. 25 MRI estimates and forecast, 2018 - 2030
  • Fig. 26 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 27 Nuclear Medicine estimates and forecast, 2018 - 2030
  • Fig. 28 Vascular imaging Market: End-use movement Analysis
  • Fig. 29 vascular imaging market: End use movement analysis
  • Fig. 30 vascular imaging market: End use outlook and key takeaways
  • Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 32 Imaging Centers market estimates and forecasts,2018 - 2030
  • Fig. 33 Others market estimates and forecasts,2018 - 2030
  • Fig. 34 Global vascular imaging market: Regional movement analysis
  • Fig. 35 Global vascular imaging market: Regional outlook and key takeaways
  • Fig. 36 Global vascular imaging market share and leading players
  • Fig. 37 North America market share and leading players
  • Fig. 38 Europe market share and leading players
  • Fig. 39 Asia Pacific market share and leading players
  • Fig. 40 Latin America market share and leading players
  • Fig. 41 Middle East & Africa market share and leading players
  • Fig. 42 North America, by country
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 49 France market estimates and forecasts, 2018 - 2030
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 58 India market estimates and forecasts, 2018 - 2030
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 66 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 71 Market share of key market players- vascular imaging market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!